Category Archives: HIV/AIDS

Timothy Ray Brown, first person cured of HIV, shared his life for common good

By on .

The Berlin patient has died of cancer Timothy Ray Brown had been telling his story for a couple of years when he first was covered in Science Speaks, but still he told it with a sense of wonder at his good fortune. On the face of it, that good fortune could have been hard to […]

Long-acting injected HIV prevention effective and safe, HPTN 083 trial data shows

By on .

Amid unprecedented challenges to routine healthcare access, trial results mark a first for a critically needed HIV prevention measure  An investigational drug administered by injection every eight weeks has been found to be effective and safe in preventing HIV infection among men who have sex with men and transgender women who have sex with men, […]

COVID-19: In Amb. Birx, the White House gets a scientist, physician, public health expert and global health realist as response coordinator

By on .

If the criteria for the selection announced Wednesday night of Vice President Mike Pence to lead the U.S. efforts to contain the spread of COVID-19 seemed less than obvious to public health experts, another appointment announced today may bring a measure of reassurance. Mr. Pence faced criticism in his most prominent previous role in a […]

U.S. drug costs lead to lapsed treatment adherence, less viral suppression, more ER, hospital visits for people with HIV, study finds

By on .

From 2016 to 2017, 14% of people living with HIV in the United States did something to save money on the out-of-pocket costs of their prescription medicine. Some asked their provider for a lower-priced medicine. Some bought their medicine from another country. Some used an alternative therapy. About half of them — 7 % of […]

Rates of hepatitis B among people living with HIV more than double estimated rates across general population globally, study finds

By on .

More than 8% of people living with HIV worldwide also live with hepatitis B virus, a disease that increases death rates and accelerates liver damage among them, a study reported in Clinical Infectious Diseases found. About a quarter of those living with both infections have active replication of the hepatis B virus, that is likely […]

More than 150,000 Americans with HIV remain unaware of infection, while PrEP uptake represents fraction of need

By on .

With an ambitious, but yet to be funded federal plan to end the American HIV epidemic within the next 10 years in front of Congress, about 14% of people living with the virus have yet to be diagnosed, just 18% of people at substantial risk of becoming infected are accessing the proven preventive drug that […]

What we’re reading: A World AIDS Day look at real changes needed to end HIV’s impacts

By on .

The View From West Virginia – More than three decades after the first World AIDS Day amplified global calls for action against an escalating pandemic, the tools and the plan to end the American epidemic exist. But the view from West Virginia, described by HIV Medicine Association Chair Dr. Judith Feinberg finds policies, politics, poverty […]

WHO releases new HIV testing guidelines

By on .

With the aim to reach an estimated 8.1 million people who are living with HIV, but remain unaware of their infection, the World Health Organization today released new and updated Consolidated Guidelines on HIV Testing Services For a Changing Epidemic. The guidelines recommended strategies to accelerate linkages to care, improve outreach to the most marginalized […]

ASTMH 2019: In plans to end AIDS impacts on children, an easier trip to the clinic could make all the difference

By on .

NATIONAL HARBOR, MARYLAND – In Malawi, where more than half the population lives in poverty, the available transportation to a clinic can determine whether a child or adolescent living with HIV gets treatment adequate enough to suppress the virus. At the 68th Annual Meeting of the American Association of Tropical Medicine and Hygiene, where aisles […]

Treat all policies saw increased access, uptake of antiretroviral treatment among teenagers who had lived with the virus from infancy

By on .

Well into the era of effective treatment for HIV, a question contributed to a lag in access to the life-saving antiretroviral drugs in resource limited countries: If everyone was eligible for the medicine, would those who need it most urgently be crowded out? Just the opposite, a study tracking data on antiretroviral treatment initiation among […]